FDA Clearance Tracker · K231209
Rejoyn
Last checked: Nov 19, 2026Latest source record: Mar 30, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 30, 2024
Substantially Equivalent
Time to decision
338 days
Received Apr 27, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K231209
- Device name
- Rejoyn
- Applicant
- Otsuka America Pharmaceutical, Inc.
- Applicant location
- Rockville, MD
- Received
- Apr 27, 2023
- Decided
- Mar 30, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5801
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SAP (Computerized Behavioral Therapy Device For Depressive Disorders.).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231209
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Otsuka America Pharmaceutical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251088 · Decided Jun 30, 2025 · 82 days after receipt
Device type: Ingestible Event Marker (OZW) · Hospital Medicine & Nursing
K223463 · Decided Aug 11, 2023 · 268 days after receipt
Device type: Ingestible Event Marker (OZW) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.